ABSTRACT
INTRODUCTION
Prolonged acute coronary artery occlusion leads to myocardial infarction. Although the ischemic myocardium can be salvaged by timely reperfusion of the occluded artery, reperfusion may lead to detrimental consequences, a phenomenon called reperfusion injury, which is now known to involve extension of the infarct size and progressive induction of apoptosis over the reperfusion time. Despite extensive research on the treatment of reperfusion injury over the past several decades, few cardioprotectants have been used successfully in clinical application [Verma 2002; Girn 2007] .
Necrosis and apoptosis are 2 forms of cell death in the myocardium that have been associated with ischemia and reperfusion [Buja 1998; Takemura 2004; Abbate 2006 ]. In particular, previous studies have shown that myocardial apoptosis in the peri-infarct myocardium progressively develops from early into later phases of reperfusion, suggesting that apoptosis may participate in exacerbating myocardial injury [Zhao 2001 ]. The dynamic changes in apoptosis that occur during reperfusion may offer an opportunity for a new treatment to reduce myocardial injury through interrupting the apoptotic process.
Ischemic postconditioning is a novel strategy for attaining cardioprotection [Zhao 2006 ]. Zhao and colleagues fi rst documented that ischemic postconditioning reduces myocardial injury [Zhao 2003a [Zhao , 2003b . Most previous studies have reported that ischemic postconditioning inhibits local infl ammatory responses in the area at risk, attenuates neutrophil and endothelial cell-cell interactions, and reduces infarct size in vivo and ex vivo in small-animal models after a short period of reperfusion; however, little information is available about whether cardioprotection with postconditioning persists after prolonged reperfusion [Zhao 2003a; Kin 2004; Yang 2005; Crisostomo 2006; Iliodromitis 2006; Mykytenko 2007] . Data suggest that reperfusion injury begins during the fi rst minutes of refl ow [Kin 2004 ] and may continue for several days [Zhao 2000; Piper 2004] . Although previous studies have found that postconditioning reduces infarct size after a prolonged period 
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of reperfusion, they did not examine whether protection by postconditioning is linked to the inhibition of apoptosis, which is potentially involved in long-term reperfusion-mediated myocardial injury [Argaud 2005; Mykytenko 2007 ]. In addition, to the best of our knowledge, little work relevant to cardioprotection with postconditioning has yet been performed in a large animal closed-chest model of myocardial infarction [Zhao 2003b; Kin 2004; Couvreur 2006; Iliodromitis 2006; Schwartz 2006; Mykytenko 2007] . In the present study, we used a closed-chest pig model of myocardial infarction to investigate infarct size, apoptosis, and apoptosis-related molecules in the peri-infarct myocardium. The objective of this study was to evaluate the hypothesis that ischemic postconditioning reduces myocardial ischemia-reperfusion (I/R) injury by inhibiting apoptosis after prolonged reperfusion (72 hours).
METHODS

Experimental Animals and Closed-Chest Model of Myocardial Infarction
Fifteen healthy Diannan small-ear pigs (19-24.5 kg; Laboratory Animal Center, Kunming Medical College, Kunming, China) were included in the experiment. The project was approved by our experimental animal committee, and the procedures were performed according to the Guide for the Care and Use of Laboratory Animals [ILAR 1996] .
All animals were fasted for 6 hours before the experiments were conducted. All interventions were performed with the animal under general anesthesia, which was introduced with intravenously administered pentobarbital sodium (20-30 mg/kg body weight initially and 2-5 mg/kg as needed). An intravenous catheter was introduced into an ear vein for the administration of pentobarbital sodium for the subsequent experiments. A 6F arterial sheath (B. Braun Melsungen, Melsungen, Germany) was placed in the right femoral artery in all animals after local surgical preparation. Before coronary catheterization, 8000 IU heparin was administered by intravenous injection, and an additional 2000 IU was injected per hour to prevent clotting during the experiment. Digital angiography (FD10 models; Philips Healthcare, Best, the Netherlands) was used in all cases. Pigs were placed in the supine position, and a 6F guiding catheter (B. Braun Melsungen) was advanced through the introducer sheath into the ostium of the left main coronary artery. A baseline coronary angiogram was obtained to delineate the vessel and to plan the location of the occlusion. Then, a guidewire was advanced through the guiding catheter into the left anterior descending coronary artery (LAD). A percutaneous transluminal coronary angioplasty balloon catheter (B. Braun Melsungen) was introduced and directed to the distal position of the fi rst diagonal artery and proximal to the second diagonal artery of the LAD. Balloon catheters with a 2-to 3-mm balloon were used, depending on the size of the individual vessels. The balloon was carefully infl ated to 3 to 4 atmospheres; complete occlusion of the vessel was confi rmed by angiography and by the presence of typical changes in the electrocardiogram, such as elevation of the T wave as a fi rst sign and, later, ST elevation. The occlusion time was 60 minutes.
Experimental Protocol
After preparation was fi nished, each animal was randomly assigned to one of the following 3 groups (n = 5 per group): (1) the sham group, in which animals underwent an experimental protocol identical to that of the other groups but without ischemia; (2) the I/R group, in which animals underwent 60 minutes of LAD occlusion followed by 72 hours of reperfusion without additional intervention; and (3) the ischemic postconditioning group, in which animals were treated the same as the I/R group except that the pigs underwent 8 cycles of 30 seconds of reperfusion and 30 seconds of ischemia before reperfusion.
Lidocaine (1-2 mg/kg) was administered intravenously to suppress ventricular arrhythmias during coronary artery occlusion. If a heart developed ventricular fi brillation or sustained ventricular tachycardia, we immediately used nonsynchronized direct current defi brillation (Heartstart XL M4735; Philips). We chose 150 J and pressed the paddles against the anterior chest wall above the sternum on the right side and below the sternum on the left. To reduce resistance and avoid skin burning, we applied ultrasound gel to the paddles.
After the balloon and arterial sheath were removed, 4 × 10 6 U penicillin was administered intravenously before the animal was taken back to the Animal Services Center. All pigs were maintained under standard laboratory conditions of temperature, humidity, and a 12-hour day/12-hour night cycle. Animals were allowed free access to food and water.
Measurement of Infarct Size
After 72 hours of reperfusion, pigs were anesthetized with pentobarbital sodium. To assess infarction size, we excised the hearts and cut them into transverse slices 4 to 5 mm thick. Each heart slice was then incubated for 15 minutes at 37°C in a 1% solution of 2,3,5-triphenyltetrazolium chloride (TTC). This method reliably identifi es necrotic myocardium, which appears pale, and viable myocardium, which stains brick red [Khalil 2006 ]. We then scanned the slices from both sides with a fl atbed scanner for further planimetry analysis of the necrotic area. The size of the infarcted tissue was measured with the public domain NIH Image program (developed at the US National Institutes of Health and available on the Internet at http://rsb.info.nih.gov/nih-image/) and was expressed as a percentage of the left ventricular surface area [Krombach 2005] . To calculate infarct size, we used the mean value of the scans of the 2 sides of each slice.
Assessment of Apoptosis in Peri-infarct Myocardium
Apoptosis was analyzed in 1 left ventricular section obtained from the sample that showed the maximal infarct size. After the 72 hours of reperfusion, a tissue sample extending 0.5 to 1.0 mm from the infarcted zone was obtained from the myocardium. This sample was considered to represent the periinfarct myocardium, as described previously [Palojoki 2001 ].
Apoptotic cardiomyocytes were detected with a terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) assay, as described previously [Zhao 2001 ]. The TUNEL technique was used to assess DNA damage. The positively labeled nuclei (brown color) were distinguished from the negative unstained nuclei (blue color), which were counterstained with hematoxylin. The TUNEL-positive nuclei were visually quantifi ed in 5 random visual microscope fi elds under high-power magnifi cation (×400) by an investigator who was blinded to the studies. Apoptotic index was calculated as the percentage of TUNEL-positive cell with the following formula: (number of TUNEL-positively stained apoptotic myocytes/total number of myocytes counts × 100) [Gao 2004 ].
Western Blot Analysis
Bcl-2 and Bax proteins were detected with western blot analysis. In brief, tissue samples from peri-infarct zones were homogenized in ice-cold lysis buffer. The protein content was measured with a Coomassie brilliant blue protein assay. Equal amounts of protein (40 μg) were loaded per lane of an 8% polyacrylamide gel for separation by electrophoresis at 100 to 200 V. Proteins were then transferred to nitrocellulose membranes at 10 V for 50 to 70 minutes. The membranes had been blocked with 5% nonfat dry milk in 1× Tris-borate-EDTA buffer containing 0.1% polysorbate 20 (Tween 20) at 25°C with gentle shaking for 2 hours. The nitrocellulose membrane was then incubated overnight at 4°C with a rabbit antibody (1:200 dilution) specifi c for Bcl-2 or Bax and then treated with a horseradish peroxidase-conjugated secondary antibody for 2 hours at 25°C. Antibody labeling was detected with a chemiluminescence assay kit. After stripping, the same nitrocellulose membrane was incubated with anti-β-actin antibody (1:800) as an internal control. Western blotting results were quantifi ed by relative density, which was calculated according to the following formula: Relative Density = (Density of Tested Band)/(Density of the β-Actin Band of the Same Sample).
Statistical Analyses
All data are expressed as the mean ± SEM. We used 1-way analysis of variance along with the Student-Newman-Keuls test for multiple comparisons. Differences were considered statistically signifi cant for P levels <.05.
RESULTS
Ischemic Postconditioning Attenuated Infarct Size
TTC staining showed that sham-operated pigs had no infarctions. Compared with the I/R group, the ischemic postconditioning group had a signifi cantly reduced mean (±SEM) infarct size (from 23.26% ± 3.13% to 10.89% ± 2.02%, P < .05) (Figure 1 ).
Detection of TUNEL-Positive Cells in the Peri-infarct Myocardium
TUNEL staining of nuclei is accepted to be both specifi c and sensitive to apoptotic cell death. In the present study, TUNEL-positive and -negative nuclei stained brown and blue, respectively. In the TUNEL assay, a large number of TUNEL-positive cells were observed in the periinfarct myocardium of pigs subjected to I/R injury, whereas TUNEL-positive cells were not detected in the sham group. The percentage of TUNEL-positive cells in the peri-infarct myocardial tissue samples from the ischemic postconditioning group (apoptotic index, 15.31% ± 4.58%) was significantly lower than in the I/R group (apoptotic index, 33.83% ± 4.44%; P < .05) (Figure 2) .
Expression of Bcl-2 and Bax Proteins in the Peri-infarct Zone
Compared with the sham group, the I/R group showed signifi cantly increased expression of Bcl-2 (0.433 ± 0.102 versus 0.151 ± 0.019, P < .05) and Bax (1.267 ± 0.308 versus 1.068 ± 0.010, P < .05). Compared with the I/R group, the ischemic postconditioning treatment showed decreased Bax levels (0.306 ± 0.075 versus 0.433 ± 0.102, P < .05) and increased Bcl-2 levels (1.801 ± 0.227 versus 1.267 ± 0.308, P < .05) (Figure 3) . Consistent with the decreased number of TUNEL-positive cells after ischemia and reperfusion, the ischemic postconditioning treatment was associated with increased Bcl-2 expression and decreased Bax expression, compared with the I/R group. Th e Heart Surgery Forum #2010-1013
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DISCUSSION
The main fi nding in the present study of a closed-chest pig model of acute myocardial infarction was that ischemic postconditioning decreased infarct size and inhibited apoptosis. These results were maintained after 72 hours of reperfusion. The signifi cant cardioprotection observed in the present study is consistent with the reductions in infarct size previously reported for studies in animal models [Zhao 2003a [Zhao , 2003b Kin 2004; Yang 2005; Crisostomo 2006; Iliodromitis 2006; Mykytenko 2007] and humans [Staat 2005] . These results suggest that postconditioning provides long-term cardioprotection via antiapoptotic mechanisms.
The phenomenon of reperfusion inducing or accelerating myocardial apoptosis has been well confi rmed in different animal species and humans [Buja 1998; Zhao 2001; Takemura 2004; Abbate 2006; Abbate 2008] . Recent studies have found that during extended reperfusion the number of apoptotic cells in the peri-infarct myocardium progressively increases after a fi xed ischemic event, a fi nding suggesting a role for apoptosis in the development of myocardial infarction [Zhao 2001] . It is conceivable, therefore, that apoptotic cells detected in the peri-infarct myocardium may undergo secondary necrosis and that the extension of the infarction may be elicited in part from the delayed apoptosis occurring during reperfusion. If apoptosis modulates the end stage of reperfusion injury, the ideal preventive or therapeutic approach would therefore target apoptosis occurring after I/R.
Although some studies have found that postconditioning reduces infarct size after prolonged reperfusion, they did not investigate whether this cardioprotection by postconditioning was related to apoptosis inhibition [Argaud 2005; Mykytenko 2007] . Our study has shown that ischemic postconditioning at the onset of reperfusion produced signifi cant reductions in infarct size and apoptosis in the peri-infarct myocardium after 72 hours of reperfusion, which were demonstrated with TTC staining and the TUNEL assay. To further clarify the mechanism of ischemic postconditioning protection, we investigated the expression of key apoptosis-related molecules. Our study showed that ischemic postconditioning increased the level of the antiapoptotic Bcl-2 protein and inhibited the expression of the proapoptotic Bax protein in the peri-infarct myocardium. Our study has provided direct evidence that extension of infarct size can be limited by ischemic postconditioning inhibition of apoptosis. Moreover, ischemic postconditioning triggered cardioprotection, possibility by regulating the Bcl-2 family to maintain myocardial stabilization. Whether other endogenous protective molecules besides the Bcl-2 family of proteins are involved in the protection afforded by ischemic postconditioning in myocardial infarction requires further study.
There is increasing evidence from experiments with rat, rabbit, and canine models that postconditioning limits infarct size both in situ and ex vivo, but the effects on larger animals are not yet clear. Schwartz and Lagranha [Schwartz 2006 ] have reported that postconditioning was ineffective in pigs, a large-animal species that should be most relevant to humans, whereas Iliodromitis and colleagues [Iliodromitis 2006 ] reported good protection in experiments with openchest pigs but also found that such protection required more than 4 I/R cycles.
Whether a large animal such as the pig can be postconditioned is a very important question, because it is directly associated with the likelihood that human hearts can be protected effectively and reliably with postconditioning. In our study, we used 8 I/R cycles in our experiments, which demonstrated that an effective postconditioning protocol could limit infarct size in pigs. Whether ischemic postconditioning played a role in the number and duration of occlusions was not fully elucidated in this study, and the I/R protocol we used may not afford the maximal protective effect against myocardial I/R injury. Thus, determining the optimal number of intervals and cycles may also require additional investigation.
Furthermore, many studies describing reductions in postischemic injury via postconditioning have now been reported for small-animal models, such as rats, rabbits, and canines. Ischemia is often created in these studies by ligating a coronary artery after surgical opening of the chest and exposure of the heart, but the experience with closed-chest investigations with larger animals is not as clear [Zhao 2003a [Zhao , 2003b Kin 2004 Kin , 2005 Iliodromitis 2006; Schwartz 2006; Mykytenko 2007] . In the present study, we successfully performed balloon occlusion of the LAD in a closed-chest pig model of myocardial infarction. Compared with open-chest surgery, the present technique avoids extensive surgery, allows control of both the location and time of the occlusion, and is the closest to the process of clinical practice.
In conclusion, our study has demonstrated that ischemic postconditioning consistently reduces infarct size and attenuates apoptosis in the peri-infarct myocardium in the closedchest pig model of myocardial infarction. This prolonged cardioprotective effect is likely achieved via antiapoptotic mechanisms.
